Cytogrowth Solutions to Present at the 7th Annual TIL Therapies Summit

This week, Cytogrowth Solutions, in collaboration with the Oklahoma Blood Institute, will share groundbreaking data at the 7th Annual TIL Therapies Summit. The focus of the presentation will be on our innovative off-the-shelf feeder cell, a GMP patent-pending product that offers a transformative alternative to irradiated leukopaks.

Our new feeder cell product is specifically designed to serve as a primary source of feeder cells for both NK (Natural Killer) and TIL (Tumor-Infiltrating Lymphocyte) therapies. This development not only streamlines the manufacturing process but also enhances the efficiency and effectiveness of cell-based therapies.

Join us at the summit to learn more about how our off-the-shelf solution is set to advance the field of immunotherapy and improve patient outcomes.